1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Diagnostic Biomarkers Industry 1.7 COVID-19 Impact: Diagnostic Biomarkers Market Trends 2 Global Diagnostic Biomarkers Quarterly Market Size Analysis 2.1 Diagnostic Biomarkers Business Impact Assessment - COVID-19 2.1.1 Global Diagnostic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Diagnostic Biomarkers Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 By Players, Global Diagnostic Biomarkers Quarterly Market Size, 2019 VS 2020 3.2 By Players, Diagnostic Biomarkers Headquarters and Area Served 3.3 Date of Key Players Enter into Diagnostic Biomarkers Market 3.4 Key Players Diagnostic Biomarkers Product Offered 3.5 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Diagnostic Biomarkers Segments, By Type 4.1 Introduction 1.4.1 Safety Biomarkers 1.4.2 Efficacy Biomarkers 1.4.3 Validation Biomarkers 4.2 By Type, Global Diagnostic Biomarkers Market Size, 2019-2021 5 Impact of Covid-19 on Diagnostic Biomarkers Segments, By Application 5.1 Overview 5.5.1 Hospitals 5.5.2 Cancer Research Institutes 5.5.3 Diagnostic Labs 5.2 By Application, Global Diagnostic Biomarkers Market Size, 2019-2021 5.2.1 By Application, Global Diagnostic Biomarkers Market Size by Application, 2019-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Qiagen N.V. 7.1.1 Qiagen N.V. Business Overview 7.1.2 Qiagen N.V. Diagnostic Biomarkers Quarterly Revenue, 2020 7.1.3 Qiagen N.V. Diagnostic Biomarkers Product Introduction 7.1.4 Qiagen N.V. Response to COVID-19 and Related Developments 7.2 Perkinelmer, Inc. 7.2.1 Perkinelmer, Inc. Business Overview 7.2.2 Perkinelmer, Inc. Diagnostic Biomarkers Quarterly Revenue, 2020 7.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Product Introduction 7.2.4 Perkinelmer, Inc. Response to COVID-19 and Related Developments 7.3 Merck Millipore 7.3.1 Merck Millipore Business Overview 7.3.2 Merck Millipore Diagnostic Biomarkers Quarterly Revenue, 2020 7.3.3 Merck Millipore Diagnostic Biomarkers Product Introduction 7.3.4 Merck Millipore Response to COVID-19 and Related Developments 7.4 Bio-Rad Laboratories, Inc. 7.4.1 Bio-Rad Laboratories, Inc. Business Overview 7.4.2 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Quarterly Revenue, 2020 7.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product Introduction 7.4.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments 7.5 Enzo Biochem, Inc. 7.5.1 Enzo Biochem, Inc. Business Overview 7.5.2 Enzo Biochem, Inc. Diagnostic Biomarkers Quarterly Revenue, 2020 7.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Product Introduction 7.5.4 Enzo Biochem, Inc. Response to COVID-19 and Related Developments 7.6 EKF Diagnostics Holdings, Inc. 7.6.1 EKF Diagnostics Holdings, Inc. Business Overview 7.6.2 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Quarterly Revenue, 2020 7.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product Introduction 7.6.4 EKF Diagnostics Holdings, Inc. Response to COVID-19 and Related Developments 7.7 Meso Scale Diagnostics, LLC. 7.7.1 Meso Scale Diagnostics, LLC. Business Overview 7.7.2 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Quarterly Revenue, 2020 7.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product Introduction 7.7.4 Meso Scale Diagnostics, LLC. Response to COVID-19 and Related Developments 7.8 Biosims Technologies Sas 7.8.1 Biosims Technologies Sas Business Overview 7.8.2 Biosims Technologies Sas Diagnostic Biomarkers Quarterly Revenue, 2020 7.8.3 Biosims Technologies Sas Diagnostic Biomarkers Product Introduction 7.8.4 Biosims Technologies Sas Response to COVID-19 and Related Developments 7.9 Cisbio Bioassays 7.9.1 Cisbio Bioassays Business Overview 7.9.2 Cisbio Bioassays Diagnostic Biomarkers Quarterly Revenue, 2020 7.9.3 Cisbio Bioassays Diagnostic Biomarkers Product Introduction 7.9.4 Cisbio Bioassays Response to COVID-19 and Related Developments 7.10 Signosis, Inc 7.10.1 Signosis, Inc Business Overview 7.10.2 Signosis, Inc Diagnostic Biomarkers Quarterly Revenue, 2020 7.10.3 Signosis, Inc Diagnostic Biomarkers Product Introduction 7.10.4 Signosis, Inc Response to COVID-19 and Related Developments 7.11 Banyan Biomarkers, Inc 7.11.1 Banyan Biomarkers, Inc Business Overview 7.11.2 Banyan Biomarkers, Inc Diagnostic Biomarkers Quarterly Revenue, 2020 7.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Product Introduction 7.11.4 Banyan Biomarkers, Inc Response to COVID-19 and Related Developments 7.12 Biomedical Corp 7.12.1 Biomedical Corp Business Overview 7.12.2 Biomedical Corp Diagnostic Biomarkers Quarterly Revenue, 2020 7.12.3 Biomedical Corp Diagnostic Biomarkers Product Introduction 7.12.4 Biomedical Corp Response to COVID-19 and Related Developments 8 Key Findings 9 Appendix 9.1 About US 9.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Diagnostic Biomarkers Assessment Table 9. COVID-19 Impact: Diagnostic Biomarkers Market Trends Table 10. COVID-19 Impact Global Diagnostic Biomarkers Market Size Table 11. Global Diagnostic Biomarkers Quarterly Market Size, 2020 (US$ Million) Table 12. Global Diagnostic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 13. Global Diagnostic Biomarkers Market Growth Drivers Table 14. Global Diagnostic Biomarkers Market Restraints Table 15. Global Diagnostic Biomarkers Market Opportunities Table 16. Global Diagnostic Biomarkers Market Challenges Table 17. By Players, Diagnostic Biomarkers Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 18. Key Players, Diagnostic Biomarkers Revenue Market Share, 2019 VS 2020 (%) Table 19. Key Diagnostic Biomarkers Players Headquarters and Area Served Table 20. Date of Key Players Enter into Diagnostic Biomarkers Market Table 21. Key Players Diagnostic Biomarkers Product Type Table 22. Mergers & Acquisitions, Expansion Plans Table 23. By Players, Global Diagnostic Biomarkers Market Size 2019-2021, (US$ Million) Table 24. Global Diagnostic Biomarkers Market Size by Application: 2019-2021 (US$ Million) Table 25. Global Diagnostic Biomarkers Market Size by Region, 2019-2021 (US$ Million) Table 26. By Country, North America Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 27. By Type, US Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 28. By Application, US Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 29. By Type, Canada Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 30. By Application, Canada Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 32. By Country, Europe Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 33. By Type, Germany Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 34. By Application, Germany Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 35. By Type, France Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 36. By Application, France Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 37. By Type, UK Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 38. By Application, UK Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 39. By Type, Italy Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 40. By Application, Italy Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 42. By Region, Asia-Pacific Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 43. By Type, China Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 44. By Application, China Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 45. By Type, Japan Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 46. By Application, Japan Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 47. By Type, South Korea Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 48. By Application, South Korea Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 49. By Type, India Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 50. By Application, India Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 51. By Type, ASEAN Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 52. By Application, ASEAN Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 53. By Type, Latin America Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 54. By Application, Latin America Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 55. By Type, Middle East and Africa Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 56. By Application, Middle East and Africa Diagnostic Biomarkers Market Size, 2019-2021 (US$ Million) Table 57. Qiagen N.V. Business Overview Table 58. Qiagen N.V. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Qiagen N.V. Diagnostic Biomarkers Product Table 60. Qiagen N.V. Response to COVID-19 and Related Developments Table 61. Perkinelmer, Inc. Business Overview Table 62. Perkinelmer, Inc. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Perkinelmer, Inc. Diagnostic Biomarkers Product Table 64. Perkinelmer, Inc. Response to COVID-19 and Related Developments Table 65. Merck Millipore Business Overview Table 66. Merck Millipore Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Merck Millipore Diagnostic Biomarkers Product Table 68. Merck Millipore Response to COVID-19 and Related Developments Table 69. Bio-Rad Laboratories, Inc. Business Overview Table 70. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product Table 72. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments Table 73. Enzo Biochem, Inc. Business Overview Table 74. Enzo Biochem, Inc. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Enzo Biochem, Inc. Diagnostic Biomarkers Product Table 76. Enzo Biochem, Inc. Response to COVID-19 and Related Developments Table 77. EKF Diagnostics Holdings, Inc. Business Overview Table 78. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product Table 80. EKF Diagnostics Holdings, Inc. Response to COVID-19 and Related Developments Table 81. Meso Scale Diagnostics, LLC. Business Overview Table 82. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product Table 84. Meso Scale Diagnostics, LLC. Response to COVID-19 and Related Developments Table 85. Biosims Technologies Sas Business Overview Table 86. Biosims Technologies Sas Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Biosims Technologies Sas Diagnostic Biomarkers Product Table 88. Biosims Technologies Sas Response to COVID-19 and Related Developments Table 89. Cisbio Bioassays Business Overview Table 90. Cisbio Bioassays Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Cisbio Bioassays Diagnostic Biomarkers Product Table 92. Cisbio Bioassays Response to COVID-19 and Related Developments Table 93. Signosis, Inc Business Overview Table 94. Signosis, Inc Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Signosis, Inc Diagnostic Biomarkers Product Table 96. Signosis, Inc Response to COVID-19 and Related Developments Table 97. Banyan Biomarkers, Inc Business Overview Table 98. Banyan Biomarkers, Inc Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Banyan Biomarkers, Inc Diagnostic Biomarkers Product Table 100. Banyan Biomarkers, Inc Response to COVID-19 and Related Developments Table 101. Biomedical Corp Business Overview Table 102. Biomedical Corp Diagnostic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Biomedical Corp Diagnostic Biomarkers Product Table 104. Biomedical Corp Response to COVID-19 and Related Developments List of Figures Figure 1. Diagnostic Biomarkers Product Picture Figure 2. Diagnostic Biomarkers Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Diagnostic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Diagnostic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Diagnostic Biomarkers Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Diagnostic Biomarkers Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Diagnostic Biomarkers Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Diagnostic Biomarkers Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Diagnostic Biomarkers Market Size Market Share, 2019-2021

Qiagen N.V. Perkinelmer, Inc. Merck Millipore Bio-Rad Laboratories, Inc. Enzo Biochem, Inc. EKF Diagnostics Holdings, Inc. Meso Scale Diagnostics, LLC. Biosims Technologies Sas Cisbio Bioassays Signosis, Inc Banyan Biomarkers, Inc Biomedical Corp